Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Periodontitis | 45 | 2024 | 576 | 6.030 |
Why?
|
Gingivitis | 9 | 2023 | 125 | 3.760 |
Why?
|
Alveolar Bone Loss | 14 | 2024 | 394 | 1.920 |
Why?
|
Eicosapentaenoic Acid | 15 | 2024 | 565 | 1.640 |
Why?
|
Periodontal Diseases | 9 | 2024 | 454 | 1.480 |
Why?
|
Porphyromonas gingivalis | 15 | 2023 | 165 | 1.430 |
Why?
|
Lipoxins | 10 | 2021 | 419 | 1.260 |
Why?
|
Chronic Periodontitis | 12 | 2021 | 104 | 1.200 |
Why?
|
Periodontal Ligament | 7 | 2023 | 117 | 1.070 |
Why?
|
Dental Plaque | 8 | 2021 | 214 | 1.060 |
Why?
|
Complement C3 | 4 | 2022 | 434 | 1.020 |
Why?
|
Inflammation | 27 | 2024 | 10872 | 0.980 |
Why?
|
Neutrophils | 23 | 2021 | 3786 | 0.860 |
Why?
|
Polyanhydrides | 2 | 2014 | 5 | 0.840 |
Why?
|
Calcium Hydroxide | 2 | 2014 | 15 | 0.830 |
Why?
|
Mouth | 4 | 2025 | 383 | 0.800 |
Why?
|
Bone Substitutes | 3 | 2014 | 230 | 0.800 |
Why?
|
Saliva | 10 | 2024 | 853 | 0.790 |
Why?
|
Diabetes Complications | 3 | 2020 | 1319 | 0.770 |
Why?
|
Polymethyl Methacrylate | 2 | 2014 | 132 | 0.770 |
Why?
|
Guided Tissue Regeneration, Periodontal | 2 | 2021 | 157 | 0.720 |
Why?
|
Bacteroidaceae Infections | 5 | 2019 | 32 | 0.710 |
Why?
|
Amnion | 1 | 2021 | 204 | 0.670 |
Why?
|
Peptides, Cyclic | 1 | 2021 | 391 | 0.660 |
Why?
|
Gingival Crevicular Fluid | 6 | 2021 | 96 | 0.640 |
Why?
|
Inflammation Mediators | 10 | 2024 | 1892 | 0.590 |
Why?
|
Dental Implants | 4 | 2015 | 790 | 0.580 |
Why?
|
Aggressive Periodontitis | 7 | 2015 | 59 | 0.570 |
Why?
|
Docosahexaenoic Acids | 10 | 2022 | 914 | 0.570 |
Why?
|
Fatty Acids, Monounsaturated | 2 | 2009 | 190 | 0.560 |
Why?
|
Polyhydroxyethyl Methacrylate | 2 | 2014 | 30 | 0.550 |
Why?
|
Gingiva | 7 | 2025 | 422 | 0.530 |
Why?
|
Administration, Topical | 6 | 2021 | 703 | 0.510 |
Why?
|
Dental Plaque Index | 6 | 2021 | 96 | 0.510 |
Why?
|
Tooth Socket | 2 | 2014 | 126 | 0.500 |
Why?
|
Diet, Atherogenic | 1 | 2015 | 92 | 0.490 |
Why?
|
Dental Scaling | 8 | 2024 | 109 | 0.480 |
Why?
|
Periodontal Attachment Loss | 7 | 2024 | 151 | 0.460 |
Why?
|
Diabetes Mellitus, Type 2 | 14 | 2024 | 12253 | 0.460 |
Why?
|
Cytokines | 18 | 2024 | 7453 | 0.450 |
Why?
|
Osteoclasts | 4 | 2024 | 713 | 0.440 |
Why?
|
Periodontal Index | 6 | 2021 | 150 | 0.430 |
Why?
|
Superoxides | 10 | 2013 | 389 | 0.420 |
Why?
|
Osteogenesis | 7 | 2023 | 1288 | 0.420 |
Why?
|
Dental Abutments | 1 | 2013 | 97 | 0.420 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5887 | 0.410 |
Why?
|
Diabetic Foot | 2 | 2013 | 382 | 0.410 |
Why?
|
Tissue Engineering | 1 | 2021 | 1893 | 0.370 |
Why?
|
Dental Prosthesis Retention | 1 | 2011 | 32 | 0.370 |
Why?
|
Wound Healing | 5 | 2021 | 2801 | 0.370 |
Why?
|
Titanium | 1 | 2013 | 494 | 0.350 |
Why?
|
Rabbits | 8 | 2017 | 4771 | 0.340 |
Why?
|
Fatty Alcohols | 1 | 2009 | 22 | 0.330 |
Why?
|
Root Planing | 5 | 2024 | 76 | 0.330 |
Why?
|
Gingival Diseases | 1 | 2009 | 37 | 0.330 |
Why?
|
Random Allocation | 5 | 2015 | 2396 | 0.320 |
Why?
|
Periodontal Pocket | 8 | 2024 | 174 | 0.300 |
Why?
|
Neutrophil Infiltration | 2 | 2023 | 393 | 0.290 |
Why?
|
Anti-Inflammatory Agents | 6 | 2024 | 1804 | 0.280 |
Why?
|
Cimetidine | 1 | 2006 | 76 | 0.260 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2014 | 2272 | 0.260 |
Why?
|
Mandible | 4 | 2014 | 748 | 0.250 |
Why?
|
Alveolar Process | 4 | 2019 | 290 | 0.250 |
Why?
|
Biocompatible Materials | 1 | 2014 | 1702 | 0.250 |
Why?
|
Biofilms | 4 | 2020 | 634 | 0.250 |
Why?
|
Dental Caries | 2 | 2023 | 429 | 0.240 |
Why?
|
Homeostasis | 2 | 2024 | 3348 | 0.240 |
Why?
|
Histamine H2 Antagonists | 1 | 2006 | 169 | 0.240 |
Why?
|
Klebsiella | 1 | 2024 | 49 | 0.230 |
Why?
|
Bacteria | 7 | 2025 | 2216 | 0.230 |
Why?
|
Autophagy | 2 | 2024 | 1349 | 0.230 |
Why?
|
Mouthwashes | 2 | 2004 | 57 | 0.230 |
Why?
|
Swine, Miniature | 4 | 2015 | 972 | 0.220 |
Why?
|
Diacylglycerol Kinase | 3 | 2013 | 47 | 0.220 |
Why?
|
Humans | 108 | 2025 | 767998 | 0.220 |
Why?
|
Metronidazole | 5 | 2013 | 236 | 0.210 |
Why?
|
Dental Pulp | 1 | 2023 | 81 | 0.210 |
Why?
|
Leukocytes, Mononuclear | 2 | 2024 | 1854 | 0.210 |
Why?
|
Male | 71 | 2024 | 364638 | 0.210 |
Why?
|
Group VI Phospholipases A2 | 2 | 2014 | 16 | 0.210 |
Why?
|
Atherosclerosis | 2 | 2017 | 3433 | 0.210 |
Why?
|
Receptors, Leptin | 1 | 2024 | 352 | 0.210 |
Why?
|
Phagocytosis | 4 | 2016 | 1530 | 0.210 |
Why?
|
Osseointegration | 3 | 2014 | 271 | 0.200 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 149 | 0.200 |
Why?
|
Monocytes | 8 | 2013 | 2604 | 0.200 |
Why?
|
Interleukin-8 | 4 | 2016 | 704 | 0.200 |
Why?
|
Regeneration | 2 | 2021 | 1524 | 0.200 |
Why?
|
X-Ray Microtomography | 3 | 2014 | 456 | 0.200 |
Why?
|
Oxygen | 1 | 2013 | 4269 | 0.190 |
Why?
|
Animals | 32 | 2024 | 169225 | 0.190 |
Why?
|
Immediate Dental Implant Loading | 2 | 2014 | 65 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2022 | 3514 | 0.190 |
Why?
|
Actinobacteria | 1 | 2021 | 62 | 0.190 |
Why?
|
Toll-Like Receptor 2 | 3 | 2021 | 348 | 0.180 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2021 | 120 | 0.180 |
Why?
|
Placebos | 3 | 2021 | 1667 | 0.180 |
Why?
|
Surface Properties | 2 | 2014 | 1165 | 0.180 |
Why?
|
Adult | 44 | 2024 | 223577 | 0.180 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2013 | 943 | 0.170 |
Why?
|
Alveolar Ridge Augmentation | 2 | 2014 | 206 | 0.170 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2024 | 591 | 0.170 |
Why?
|
Disease Models, Animal | 13 | 2022 | 18345 | 0.170 |
Why?
|
Periodontium | 3 | 2022 | 99 | 0.170 |
Why?
|
Salivary Proteins and Peptides | 1 | 2019 | 48 | 0.170 |
Why?
|
B-Lymphocytes | 5 | 2010 | 4791 | 0.160 |
Why?
|
Gingival Overgrowth | 2 | 2010 | 7 | 0.160 |
Why?
|
Oxidation-Reduction | 2 | 2024 | 2227 | 0.160 |
Why?
|
Symbiosis | 1 | 2021 | 297 | 0.160 |
Why?
|
Cells, Cultured | 15 | 2023 | 19015 | 0.160 |
Why?
|
Amoxicillin | 4 | 2013 | 181 | 0.160 |
Why?
|
Mitochondria | 2 | 2023 | 3681 | 0.150 |
Why?
|
Chemotaxis, Leukocyte | 5 | 2009 | 660 | 0.150 |
Why?
|
Th17 Cells | 2 | 2023 | 791 | 0.150 |
Why?
|
Esthetics, Dental | 1 | 2020 | 267 | 0.150 |
Why?
|
Acid Ceramidase | 1 | 2017 | 21 | 0.150 |
Why?
|
Fibromatosis, Gingival | 3 | 2007 | 7 | 0.150 |
Why?
|
Lymphocyte Activation | 4 | 2021 | 5505 | 0.140 |
Why?
|
Female | 60 | 2024 | 397102 | 0.140 |
Why?
|
Double-Blind Method | 7 | 2021 | 12464 | 0.140 |
Why?
|
Middle Aged | 38 | 2024 | 223422 | 0.140 |
Why?
|
Complement Activation | 1 | 2019 | 447 | 0.140 |
Why?
|
Obesity | 6 | 2024 | 13092 | 0.140 |
Why?
|
Fibroblasts | 6 | 2022 | 4176 | 0.130 |
Why?
|
Interleukin-17 | 2 | 2021 | 925 | 0.130 |
Why?
|
Toll-Like Receptors | 2 | 2010 | 582 | 0.130 |
Why?
|
C-Reactive Protein | 5 | 2022 | 3858 | 0.130 |
Why?
|
Swine | 4 | 2015 | 6002 | 0.130 |
Why?
|
Blood-Borne Pathogens | 1 | 2015 | 52 | 0.130 |
Why?
|
Interleukin-6 | 4 | 2022 | 3228 | 0.130 |
Why?
|
Glucose | 3 | 2017 | 4351 | 0.120 |
Why?
|
Fusobacterium nucleatum | 1 | 2016 | 176 | 0.120 |
Why?
|
Arthritis, Rheumatoid | 2 | 2021 | 3781 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 2 | 2019 | 1197 | 0.120 |
Why?
|
Hyperglycemia | 2 | 2022 | 1388 | 0.120 |
Why?
|
Light-Curing of Dental Adhesives | 1 | 2014 | 4 | 0.120 |
Why?
|
Intracellular Fluid | 2 | 2005 | 201 | 0.120 |
Why?
|
Interleukin-1beta | 5 | 2014 | 1027 | 0.110 |
Why?
|
RNA, Ribosomal, 16S | 4 | 2023 | 1049 | 0.110 |
Why?
|
Lipid A | 1 | 2013 | 70 | 0.110 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4857 | 0.110 |
Why?
|
Chemokine CCL2 | 1 | 2016 | 605 | 0.110 |
Why?
|
Overweight | 2 | 2023 | 2449 | 0.110 |
Why?
|
Bone Density Conservation Agents | 2 | 2019 | 797 | 0.110 |
Why?
|
Pyridones | 1 | 2019 | 819 | 0.110 |
Why?
|
Interleukin-12 | 1 | 2016 | 577 | 0.110 |
Why?
|
Mice, Transgenic | 2 | 2024 | 9556 | 0.110 |
Why?
|
Calcification, Physiologic | 1 | 2014 | 170 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 742 | 0.110 |
Why?
|
Lipopolysaccharides | 5 | 2023 | 2219 | 0.110 |
Why?
|
Peri-Implantitis | 1 | 2015 | 124 | 0.100 |
Why?
|
Glucose Intolerance | 1 | 2017 | 579 | 0.100 |
Why?
|
Dental Implantation, Endosseous | 2 | 2014 | 519 | 0.100 |
Why?
|
RNA Precursors | 1 | 2013 | 196 | 0.100 |
Why?
|
Stomatitis | 1 | 2015 | 271 | 0.100 |
Why?
|
Leukotriene B4 | 3 | 2011 | 281 | 0.100 |
Why?
|
Apoptosis | 4 | 2017 | 9521 | 0.100 |
Why?
|
Metformin | 1 | 2020 | 909 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2019 | 958 | 0.100 |
Why?
|
Hyperoxia | 1 | 2014 | 259 | 0.100 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2013 | 414 | 0.100 |
Why?
|
Toll-Like Receptor 4 | 2 | 2021 | 589 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2019 | 3447 | 0.100 |
Why?
|
Bone Regeneration | 1 | 2014 | 438 | 0.100 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 2 | 2009 | 97 | 0.100 |
Why?
|
Bone Remodeling | 1 | 2015 | 582 | 0.090 |
Why?
|
Molecular Typing | 1 | 2012 | 115 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4415 | 0.090 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2011 | 1399 | 0.090 |
Why?
|
Stem Cells | 2 | 2023 | 3537 | 0.090 |
Why?
|
Insulin Resistance | 2 | 2023 | 3986 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3951 | 0.090 |
Why?
|
Calcium Phosphates | 1 | 2012 | 173 | 0.090 |
Why?
|
Fatty Acids | 1 | 2019 | 1811 | 0.090 |
Why?
|
Ultrasonic Therapy | 1 | 2012 | 216 | 0.090 |
Why?
|
Interleukin-10 | 4 | 2012 | 1183 | 0.090 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2010 | 141 | 0.090 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.090 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 5 | 2009 | 221 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2015 | 558 | 0.090 |
Why?
|
Brazil | 3 | 2024 | 1250 | 0.090 |
Why?
|
Mice | 13 | 2024 | 82024 | 0.080 |
Why?
|
Aged | 18 | 2024 | 171453 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1622 | 0.080 |
Why?
|
Peptides | 2 | 2020 | 4354 | 0.080 |
Why?
|
Dendritic Cells | 1 | 2021 | 2746 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2016 | 4351 | 0.080 |
Why?
|
Nanostructures | 1 | 2014 | 553 | 0.080 |
Why?
|
Bicuspid | 1 | 2009 | 69 | 0.080 |
Why?
|
Acid Phosphatase | 2 | 2024 | 141 | 0.080 |
Why?
|
Erythrocytes | 2 | 2016 | 2418 | 0.080 |
Why?
|
Hemorrhage | 1 | 2021 | 3467 | 0.080 |
Why?
|
Ceruloplasmin | 1 | 2009 | 57 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1656 | 0.080 |
Why?
|
Phosphates | 1 | 2013 | 765 | 0.080 |
Why?
|
Lung Injury | 1 | 2014 | 433 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10396 | 0.080 |
Why?
|
Dinoprostone | 2 | 2013 | 597 | 0.080 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 118 | 0.080 |
Why?
|
Epithelial Cells | 3 | 2017 | 3703 | 0.080 |
Why?
|
Eubacterium | 3 | 2014 | 23 | 0.080 |
Why?
|
Tomography, Optical Coherence | 1 | 2022 | 2957 | 0.080 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8762 | 0.080 |
Why?
|
Alternative Splicing | 1 | 2013 | 1104 | 0.080 |
Why?
|
Metagenome | 1 | 2012 | 465 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2149 | 0.070 |
Why?
|
Respiratory Burst | 1 | 2008 | 110 | 0.070 |
Why?
|
Actinomyces | 2 | 2021 | 41 | 0.070 |
Why?
|
Anti-Infective Agents | 2 | 2012 | 983 | 0.070 |
Why?
|
Blood Glucose | 2 | 2020 | 6429 | 0.070 |
Why?
|
Reference Values | 1 | 2015 | 4938 | 0.070 |
Why?
|
Protein Kinase C | 3 | 2010 | 1207 | 0.070 |
Why?
|
Esterification | 1 | 2007 | 39 | 0.070 |
Why?
|
Metabolic Diseases | 1 | 2014 | 684 | 0.070 |
Why?
|
Leukocytes | 1 | 2015 | 2036 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6232 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3109 | 0.070 |
Why?
|
Materials Testing | 1 | 2011 | 873 | 0.070 |
Why?
|
Gene Expression Profiling | 4 | 2023 | 9536 | 0.070 |
Why?
|
Calcium | 3 | 2015 | 5794 | 0.070 |
Why?
|
Up-Regulation | 4 | 2013 | 4146 | 0.070 |
Why?
|
Virulence | 2 | 2021 | 1297 | 0.070 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10264 | 0.070 |
Why?
|
Diglycerides | 2 | 2005 | 176 | 0.070 |
Why?
|
Macrophages | 3 | 2015 | 5798 | 0.070 |
Why?
|
Immunity, Mucosal | 1 | 2010 | 498 | 0.070 |
Why?
|
Phosphatidate Phosphatase | 2 | 2021 | 21 | 0.070 |
Why?
|
Immunoglobulin A | 1 | 2010 | 992 | 0.070 |
Why?
|
Connective Tissue Cells | 1 | 2006 | 50 | 0.070 |
Why?
|
Doxycycline | 1 | 2009 | 348 | 0.070 |
Why?
|
Receptors, Immunologic | 3 | 2008 | 1418 | 0.070 |
Why?
|
Aspirin | 3 | 2017 | 3135 | 0.070 |
Why?
|
Anti-Bacterial Agents | 5 | 2024 | 7469 | 0.070 |
Why?
|
HL-60 Cells | 3 | 2013 | 364 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10757 | 0.060 |
Why?
|
Case-Control Studies | 9 | 2017 | 22286 | 0.060 |
Why?
|
Stress, Mechanical | 1 | 2011 | 1676 | 0.060 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2006 | 361 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3798 | 0.060 |
Why?
|
Aging | 2 | 2024 | 8745 | 0.060 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2010 | 756 | 0.060 |
Why?
|
Kuwait | 2 | 2016 | 94 | 0.060 |
Why?
|
Isoenzymes | 2 | 2024 | 1688 | 0.060 |
Why?
|
Adolescent | 11 | 2022 | 89154 | 0.060 |
Why?
|
Cell Proliferation | 5 | 2023 | 10471 | 0.060 |
Why?
|
Pilot Projects | 4 | 2022 | 8740 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6225 | 0.060 |
Why?
|
Models, Animal | 1 | 2011 | 2121 | 0.060 |
Why?
|
Tooth Bleaching | 1 | 2004 | 10 | 0.060 |
Why?
|
Platelet-Rich Plasma | 1 | 2007 | 180 | 0.060 |
Why?
|
Tooth Discoloration | 1 | 2004 | 13 | 0.060 |
Why?
|
Bone Density | 2 | 2015 | 3573 | 0.060 |
Why?
|
Chronic Disease | 4 | 2024 | 9384 | 0.060 |
Why?
|
Starvation | 1 | 2024 | 141 | 0.060 |
Why?
|
Genes, Bacterial | 2 | 2021 | 1076 | 0.060 |
Why?
|
Sodium Fluoride | 1 | 2004 | 67 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2023 | 11666 | 0.050 |
Why?
|
Immediate-Early Proteins | 1 | 2006 | 444 | 0.050 |
Why?
|
Polymers | 1 | 2011 | 1627 | 0.050 |
Why?
|
Dental Caries Susceptibility | 1 | 2023 | 28 | 0.050 |
Why?
|
Gingival Pocket | 1 | 2023 | 7 | 0.050 |
Why?
|
Metagenomics | 2 | 2020 | 474 | 0.050 |
Why?
|
Chemokine CXCL1 | 1 | 2023 | 102 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11068 | 0.050 |
Why?
|
Bacterial Typing Techniques | 1 | 2004 | 263 | 0.050 |
Why?
|
Mice, Obese | 2 | 2014 | 417 | 0.050 |
Why?
|
Gingival Hemorrhage | 2 | 2014 | 49 | 0.050 |
Why?
|
Klebsiella Infections | 1 | 2024 | 146 | 0.050 |
Why?
|
Bacterial Load | 2 | 2013 | 155 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1816 | 0.050 |
Why?
|
Risk Factors | 6 | 2024 | 74938 | 0.050 |
Why?
|
Flow Cytometry | 4 | 2016 | 5904 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2024 | 253 | 0.050 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 996 | 0.050 |
Why?
|
Nasal Cavity | 1 | 2024 | 310 | 0.050 |
Why?
|
Radiography | 2 | 2020 | 6981 | 0.050 |
Why?
|
Prospective Studies | 6 | 2023 | 54921 | 0.050 |
Why?
|
Tetracycline | 2 | 2013 | 216 | 0.050 |
Why?
|
Angiopoietins | 1 | 2022 | 86 | 0.050 |
Why?
|
Mouth Diseases | 1 | 2024 | 239 | 0.050 |
Why?
|
Propionibacteriaceae | 1 | 2021 | 10 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15662 | 0.050 |
Why?
|
Treatment Outcome | 7 | 2024 | 65360 | 0.050 |
Why?
|
Drug Combinations | 3 | 2013 | 2088 | 0.050 |
Why?
|
20-Hydroxysteroid Dehydrogenases | 1 | 2021 | 6 | 0.050 |
Why?
|
Blood Proteins | 1 | 2007 | 1191 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21533 | 0.050 |
Why?
|
Prevotella | 2 | 2013 | 81 | 0.050 |
Why?
|
Phosphorylation | 5 | 2014 | 8314 | 0.050 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2003 | 640 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2005 | 1252 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2010 | 3140 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2007 | 2450 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2014 | 12797 | 0.050 |
Why?
|
Bacteroides | 2 | 2013 | 165 | 0.050 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2021 | 175 | 0.050 |
Why?
|
Weight Gain | 2 | 2024 | 2359 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2014 | 3587 | 0.040 |
Why?
|
Cytoplasm | 1 | 2005 | 1505 | 0.040 |
Why?
|
Nose | 1 | 2024 | 522 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26377 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2014 | 474 | 0.040 |
Why?
|
Radiography, Bitewing | 1 | 2020 | 36 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 630 | 0.040 |
Why?
|
Cell Membrane | 3 | 2017 | 3657 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2004 | 740 | 0.040 |
Why?
|
Oral Surgical Procedures | 2 | 2012 | 172 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2014 | 478 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2022 | 598 | 0.040 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2021 | 306 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2012 | 3669 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 839 | 0.040 |
Why?
|
Diphosphonates | 2 | 2019 | 633 | 0.040 |
Why?
|
STAT3 Transcription Factor | 1 | 2023 | 874 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2023 | 2456 | 0.040 |
Why?
|
Collagen | 2 | 2021 | 2641 | 0.040 |
Why?
|
Body Mass Index | 4 | 2023 | 13053 | 0.040 |
Why?
|
Insulin | 3 | 2022 | 6606 | 0.040 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2015 | 638 | 0.040 |
Why?
|
Collagen Type I | 2 | 2015 | 618 | 0.040 |
Why?
|
Epithelium | 1 | 2023 | 1607 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2884 | 0.040 |
Why?
|
Phenytoin | 2 | 2010 | 189 | 0.040 |
Why?
|
Genetic Linkage | 1 | 2003 | 2342 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2010 | 2442 | 0.040 |
Why?
|
Salivary Glands | 1 | 2019 | 231 | 0.040 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2024 | 1125 | 0.040 |
Why?
|
Receptors, Death Domain | 1 | 2017 | 31 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22381 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11930 | 0.040 |
Why?
|
Risk Assessment | 2 | 2020 | 24317 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13500 | 0.040 |
Why?
|
Germany | 1 | 2020 | 882 | 0.040 |
Why?
|
Transforming Growth Factor beta | 2 | 2021 | 1995 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2010 | 3446 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 878 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2019 | 912 | 0.030 |
Why?
|
Dental Care | 1 | 2019 | 285 | 0.030 |
Why?
|
Blotting, Western | 3 | 2009 | 5023 | 0.030 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1469 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1738 | 0.030 |
Why?
|
Cognition | 2 | 2024 | 7072 | 0.030 |
Why?
|
Cisplatin | 1 | 2022 | 1658 | 0.030 |
Why?
|
Nifedipine | 2 | 2007 | 221 | 0.030 |
Why?
|
Neutrophil Activation | 2 | 2009 | 180 | 0.030 |
Why?
|
Keratinocytes | 1 | 2020 | 876 | 0.030 |
Why?
|
Sex Factors | 2 | 2024 | 10629 | 0.030 |
Why?
|
Time Factors | 4 | 2011 | 40210 | 0.030 |
Why?
|
Leptin | 2 | 2014 | 1599 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1251 | 0.030 |
Why?
|
Arachidonate 12-Lipoxygenase | 1 | 2015 | 82 | 0.030 |
Why?
|
Neoplasms | 1 | 2024 | 22369 | 0.030 |
Why?
|
Collagen Type III | 1 | 2015 | 92 | 0.030 |
Why?
|
Dental Cementum | 1 | 2014 | 53 | 0.030 |
Why?
|
Receptors, Formyl Peptide | 1 | 2015 | 146 | 0.030 |
Why?
|
Specimen Handling | 1 | 2019 | 708 | 0.030 |
Why?
|
Odds Ratio | 2 | 2004 | 9667 | 0.030 |
Why?
|
Protein Isoforms | 2 | 2013 | 1715 | 0.030 |
Why?
|
Caspases | 1 | 2017 | 882 | 0.030 |
Why?
|
Down-Regulation | 1 | 2021 | 2936 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1181 | 0.030 |
Why?
|
Biota | 1 | 2013 | 23 | 0.030 |
Why?
|
NF-kappa B | 1 | 2022 | 2493 | 0.030 |
Why?
|
Child | 6 | 2022 | 80905 | 0.030 |
Why?
|
DNA, Bacterial | 2 | 2012 | 1478 | 0.030 |
Why?
|
3T3 Cells | 1 | 2015 | 1084 | 0.030 |
Why?
|
Treponema denticola | 1 | 2013 | 13 | 0.030 |
Why?
|
Capnocytophaga | 1 | 2013 | 26 | 0.030 |
Why?
|
Myofibroblasts | 1 | 2015 | 230 | 0.030 |
Why?
|
Stomatitis, Aphthous | 1 | 1994 | 51 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2021 | 1397 | 0.030 |
Why?
|
Fusobacterium | 1 | 2013 | 56 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2040 | 0.030 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 2854 | 0.030 |
Why?
|
Triamcinolone Acetonide | 1 | 1994 | 105 | 0.030 |
Why?
|
Body Weight | 2 | 2014 | 4628 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2014 | 173 | 0.030 |
Why?
|
Concanavalin A | 1 | 2012 | 190 | 0.030 |
Why?
|
Streptococcus | 1 | 2013 | 198 | 0.030 |
Why?
|
Follow-Up Studies | 5 | 2014 | 39340 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13667 | 0.030 |
Why?
|
Interleukin-1alpha | 1 | 2012 | 88 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2024 | 81748 | 0.030 |
Why?
|
Codon, Nonsense | 1 | 2013 | 287 | 0.020 |
Why?
|
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2011 | 15 | 0.020 |
Why?
|
Cellulose | 1 | 2012 | 117 | 0.020 |
Why?
|
Nanomedicine | 1 | 2014 | 292 | 0.020 |
Why?
|
Brain | 1 | 2019 | 27366 | 0.020 |
Why?
|
Calcimycin | 1 | 2011 | 214 | 0.020 |
Why?
|
COS Cells | 1 | 2013 | 1135 | 0.020 |
Why?
|
Waist Circumference | 1 | 2015 | 935 | 0.020 |
Why?
|
Glycosylation | 1 | 2014 | 1100 | 0.020 |
Why?
|
Dietary Sucrose | 1 | 2013 | 242 | 0.020 |
Why?
|
Surgical Flaps | 2 | 2014 | 1680 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2014 | 665 | 0.020 |
Why?
|
Receptors, CCR10 | 1 | 2010 | 10 | 0.020 |
Why?
|
Fibrosis | 2 | 2010 | 2080 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2013 | 930 | 0.020 |
Why?
|
Immunoglobulin J-Chains | 1 | 2010 | 26 | 0.020 |
Why?
|
Dental Prophylaxis | 1 | 2010 | 26 | 0.020 |
Why?
|
Signal Transduction | 4 | 2010 | 23640 | 0.020 |
Why?
|
Phagocytes | 1 | 2012 | 294 | 0.020 |
Why?
|
Receptors, CCR | 1 | 2010 | 37 | 0.020 |
Why?
|
Chlorhexidine | 1 | 2012 | 159 | 0.020 |
Why?
|
Hydroxyeicosatetraenoic Acids | 1 | 2011 | 225 | 0.020 |
Why?
|
Maxillary Sinus | 1 | 2012 | 172 | 0.020 |
Why?
|
Antigens, CD | 1 | 2021 | 4035 | 0.020 |
Why?
|
Porins | 1 | 2010 | 78 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3284 | 0.020 |
Why?
|
Cohort Studies | 3 | 2021 | 41753 | 0.020 |
Why?
|
Membranes, Artificial | 1 | 2012 | 364 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1162 | 0.020 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2010 | 57 | 0.020 |
Why?
|
Dogs | 1 | 2015 | 3843 | 0.020 |
Why?
|
Selenomonas | 1 | 2009 | 11 | 0.020 |
Why?
|
Palatine Tonsil | 1 | 2010 | 193 | 0.020 |
Why?
|
Eikenella corrodens | 1 | 2009 | 17 | 0.020 |
Why?
|
Peptostreptococcus | 1 | 2009 | 27 | 0.020 |
Why?
|
Treponema | 1 | 2009 | 40 | 0.020 |
Why?
|
Campylobacter | 1 | 2009 | 58 | 0.020 |
Why?
|
Absorbable Implants | 1 | 2012 | 336 | 0.020 |
Why?
|
Ferrous Compounds | 1 | 2009 | 41 | 0.020 |
Why?
|
Proteobacteria | 1 | 2009 | 47 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2010 | 286 | 0.020 |
Why?
|
Coloring Agents | 1 | 2012 | 565 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4576 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2014 | 610 | 0.020 |
Why?
|
Bacteroidetes | 1 | 2009 | 84 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1890 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1587 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 633 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2009 | 292 | 0.020 |
Why?
|
Health | 1 | 2012 | 398 | 0.020 |
Why?
|
Maxilla | 1 | 2012 | 486 | 0.020 |
Why?
|
Prednisone | 1 | 1994 | 1567 | 0.020 |
Why?
|
Logistic Models | 1 | 2004 | 13289 | 0.020 |
Why?
|
P-Selectin | 1 | 2011 | 598 | 0.020 |
Why?
|
Threonine | 1 | 2009 | 273 | 0.020 |
Why?
|
Oxidants | 1 | 2009 | 168 | 0.020 |
Why?
|
Anticonvulsants | 2 | 2010 | 1922 | 0.020 |
Why?
|
Cytochromes c | 1 | 2009 | 173 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2014 | 733 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2024 | 14484 | 0.020 |
Why?
|
Staurosporine | 1 | 2009 | 241 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2012 | 1157 | 0.020 |
Why?
|
Virulence Factors | 1 | 2012 | 502 | 0.020 |
Why?
|
Physical Fitness | 1 | 2013 | 744 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2014 | 2678 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1013 | 0.020 |
Why?
|
RANK Ligand | 1 | 2010 | 321 | 0.020 |
Why?
|
Gram-Positive Bacteria | 1 | 2009 | 179 | 0.020 |
Why?
|
Models, Biological | 1 | 2025 | 9493 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2543 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1346 | 0.020 |
Why?
|
Adiponectin | 1 | 2014 | 1117 | 0.020 |
Why?
|
Ileum | 1 | 2010 | 558 | 0.020 |
Why?
|
tau Proteins | 1 | 2019 | 2144 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1193 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1561 | 0.020 |
Why?
|
Actins | 1 | 2015 | 2064 | 0.020 |
Why?
|
Metals | 1 | 2012 | 713 | 0.020 |
Why?
|
Gram-Negative Bacteria | 1 | 2009 | 275 | 0.020 |
Why?
|
Exons | 1 | 2013 | 2393 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2012 | 800 | 0.020 |
Why?
|
Chemotaxis | 1 | 2010 | 600 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2009 | 376 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17128 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1793 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2009 | 858 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12536 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1340 | 0.020 |
Why?
|
Zymosan | 1 | 2006 | 134 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9368 | 0.020 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2007 | 284 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 753 | 0.020 |
Why?
|
Fibronectins | 1 | 2010 | 722 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2006 | 91 | 0.020 |
Why?
|
Chemokine CCL5 | 1 | 2007 | 214 | 0.020 |
Why?
|
Gene Targeting | 1 | 2010 | 841 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 610 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2009 | 393 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2019 | 5151 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1904 | 0.020 |
Why?
|
S100 Proteins | 1 | 2006 | 215 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1551 | 0.020 |
Why?
|
Serine | 1 | 2009 | 831 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3912 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5757 | 0.020 |
Why?
|
Densitometry | 1 | 2005 | 151 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3433 | 0.020 |
Why?
|
Integrins | 1 | 2010 | 842 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2010 | 1527 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2006 | 826 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 904 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2010 | 1083 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2019 | 3914 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 977 | 0.020 |
Why?
|
Caspase 3 | 1 | 2007 | 730 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2012 | 1667 | 0.020 |
Why?
|
Chemotactic Factors | 1 | 2005 | 197 | 0.020 |
Why?
|
Molecular Weight | 1 | 2007 | 2173 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 1168 | 0.010 |
Why?
|
Diltiazem | 1 | 2005 | 132 | 0.010 |
Why?
|
Flavonoids | 1 | 2008 | 447 | 0.010 |
Why?
|
Cyclosporine | 1 | 2007 | 778 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 694 | 0.010 |
Why?
|
Verapamil | 1 | 2005 | 242 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2012 | 1063 | 0.010 |
Why?
|
Tooth Mobility | 1 | 2004 | 20 | 0.010 |
Why?
|
Bacteria, Anaerobic | 1 | 2004 | 71 | 0.010 |
Why?
|
Gingivectomy | 1 | 2004 | 14 | 0.010 |
Why?
|
Platelet Count | 1 | 2007 | 786 | 0.010 |
Why?
|
Cell Migration Inhibition | 1 | 2004 | 97 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2007 | 688 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 775 | 0.010 |
Why?
|
Substance P | 1 | 2005 | 331 | 0.010 |
Why?
|
Lysophospholipids | 1 | 2006 | 337 | 0.010 |
Why?
|
Chile | 1 | 2004 | 258 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 2006 | 564 | 0.010 |
Why?
|
Immunosuppressive Agents | 2 | 2007 | 4210 | 0.010 |
Why?
|
Thrombosis | 1 | 2017 | 2957 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 3553 | 0.010 |
Why?
|
Gene Silencing | 1 | 2009 | 1505 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 1305 | 0.010 |
Why?
|
Temperature | 1 | 2009 | 2234 | 0.010 |
Why?
|
Cell Line | 1 | 2016 | 15597 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15867 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2006 | 1892 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 2004 | 473 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10590 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3159 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1951 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2006 | 751 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 1997 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59600 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9609 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1550 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 3079 | 0.010 |
Why?
|
Vitamin D | 1 | 2015 | 3312 | 0.010 |
Why?
|
Sweden | 1 | 2004 | 1382 | 0.010 |
Why?
|
Heart Rate | 1 | 2013 | 4215 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5209 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4063 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3055 | 0.010 |
Why?
|
Blood Platelets | 1 | 2011 | 2477 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 2230 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 13489 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2487 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3428 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6786 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2007 | 1625 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3044 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15443 | 0.010 |
Why?
|
United States | 2 | 2024 | 73033 | 0.010 |
Why?
|
Imidazoles | 1 | 2005 | 1168 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3726 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 30244 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2906 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8536 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16723 | 0.010 |
Why?
|
Crohn Disease | 1 | 2010 | 2295 | 0.010 |
Why?
|
Gene Expression | 1 | 2010 | 7597 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2014 | 9016 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2008 | 5798 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 2722 | 0.010 |
Why?
|
Blood Pressure | 1 | 2013 | 8539 | 0.010 |
Why?
|
Genetic Variation | 1 | 2012 | 6612 | 0.010 |
Why?
|
Escherichia coli | 1 | 2008 | 4215 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13420 | 0.010 |
Why?
|
Smoking | 1 | 2012 | 9087 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29984 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2007 | 17617 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6070 | 0.010 |
Why?
|
Young Adult | 2 | 2010 | 60050 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12417 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4427 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42665 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2005 | 7876 | 0.000 |
Why?
|